Broadening the spectrum of controls for skin biopsy in painful neuropathies: spondylotic cervical myelopathy patients with painful feet
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26925305
PubMed Central
PMC4754497
DOI
10.1002/brb3.444
PII: BRB3444
Knihovny.cz E-zdroje
- Klíčová slova
- Cervical spondylotic myelopathy, epidermal nerve fibers, neuropathic pain, peripheral neuropathy, skin biopsy,
- MeSH
- bolest diagnóza MeSH
- jehlová biopsie normy statistika a číselné údaje MeSH
- kohortové studie MeSH
- kůže chemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nemoci míchy MeSH
- nemoci periferního nervového systému diagnóza patofyziologie MeSH
- nervová vlákna fyziologie MeSH
- noha (od hlezna dolů) patofyziologie MeSH
- spondylóza komplikace MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Intraepidermal nerve fiber density (IENFD) is useful in the evaluation of small-fiber neuropathy (SFN). Recent guidelines recommend extending the spectrum of controls for IENFD assessment by evaluation of patients whose clinical picture mimics that of SFN. The aim of this study was to broaden the spectrum of IENFD controls by the assessment of patients with cervical spondylotic myelopathy (CSM) and painful feet. METHODS: Evaluation of IENFD from skin biopsy samples and quantitative sensory testing (QST) were performed in a cohort of 14 CSM patients (eight men, median age: 58; range: 46-63 years), with painful feet, exhibiting no clinical or electrophysiological signs of large-fiber polyneuropathy, and no risk factors for peripheral neuropathies. RESULTS: Quantitative sensory testing abnormalities were found in all but two of the CSM patients (86%), while the IENFD values were within reference range. The mean IENFD value (6.87 ± 2.78 fibers/mm) did not differ from that of an age- and sex-matched cohort of healthy volunteers (7.97 ± 2.21 fibers/mm, P > 0.05). CONCLUSIONS: The study confirmed normal skin biopsy findings in patients with CSM as one of the clinical conditions mimicking SFN and provided further support for the use of IENFD assessment in case of suspicion of SFN.
Zobrazit více v PubMed
Bednarík, J. , Kadanka Z., Vohánka S., Stejskal L., Vlach O., and Schröder R.. 1999. The value of somatosensory‐ and motor‐evoked potentials in predicting and monitoring the effect of therapy in spondylotic cervical myelopathy. Prospective randomized study. Spine (Phila Pa 1976) 24:1593–1598. PubMed
Benzel, E. C. , Lancon J., Kesterson L., and Hadden T.. 1991. Cervical laminectomy and dentate ligament section for cervical spondylotic myelopathy. J. Spinal Disord. 4:286–295. PubMed
Bursova, S. , Vlckova E., Hnojcikova M., Nemec M., Dubovy P., Micankova‐Adamova B., et al. 2012. Intraepidermal nerve fiber density assessment in skin biopsy – normative values. Cesk. Slov. Neurol. N. 75:455–459.
Emery, S. E. 2001. Cervical spondylotic myelopathy: diagnosis and treatment. J. Am. Acad. Orthop. Surg. 9:376–388. PubMed
England, J. D. , Gronseth G. S., Franklin G., Carter G. T., Kinsella L. J., Cohen J. A., et al. 2009. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence‐based review). Muscle Nerve 39:106–115. PubMed
Herrmann, D. N. , O'Connor A. B., Schwid S. R., Da Y., Goodman A. D., Rafferty J., et al. 2010. Broadening the spectrum of controls for skin biopsy in painful neuropathies. Muscle Nerve 42:436–438. PubMed
Lacomis, D. 2002. Small‐fiber neuropathy. Muscle Nerve 26:173–188. PubMed
Lauria, G. , Bakkers M., Schmitz C., Lombardi R., Penza P., Devigili G., et al. 2010a. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. Peripher. Nerv. Syst. 15:202–207. PubMed
Lauria, G. , Hsieh S. T., Johansson O., Kennedy W. R., Leger J. M., Mellgren S. I., et al. 2010b. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur. J. Neurol. 17:903–912. PubMed
Magerl, W. , Krumova E. K., Baron R., Tölle T., Treede R. D., and Maier C.. 2010. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 151:598–605. PubMed
Peters, M. J. , Bakkers M., Merkies I. S., Hoeijmakers J. G., van Raak E. P., and Faber C. G.. 2013. Incidence and prevalence of small‐fiber neuropathy: a survey in the Netherlands. Neurology 81:1356–1360. PubMed
Rolke, R. , Baron R., Maier C., Tölle T. R., Treede R. D., Beyer A., et al. 2006. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123:231–243. PubMed
Skorna, M. , Kopacik R., Vlckova E., Adamova B., Kostalova M., and Bednarik J.. 2015. Small nerve fiber pathology in critically illness documented by serial skin biopsies. Muscle Nerve 52:28–33. PubMed
Srotova, I. , Vlckova E., Strakova J., Kincova S., Adamova B., Dusek L., et al. 2015. Validation of Czech version of DFNS protocol for quantitative sensory testing]. Cesk. Slov. Neurol. N. 78:442–452.
Vlckova‐Moravcova, E. , Bednarik J., Dušek L., Toyka K. V., and Sommer C.. 2008. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 37:50–60. PubMed
Yonenobu, K. , Abumi K., Takeomi E., and Ueyama K.. 2001. Interobserver and intraobserver reliability of the Japanese Orthopaedic Association scoring system for evaluation of cervical compression myelopathy. Spine (Phila Pa 1976) 26:1890–1894. PubMed
Yoshiyama, Y. , Tokumaru Y., Hattori T., and Hirayama K.. 1995. The “pseudo‐polyneuropathy” type sensory disturbances in cervical spondylotic myelopathy. Rinsho Shinkeigaku (Clin. Neurol.) 35:141–146. PubMed